Aspen Pharmacare Holdings Ltd banner
A

Aspen Pharmacare Holdings Ltd
JSE:APN

Watchlist Manager
Aspen Pharmacare Holdings Ltd
JSE:APN
Watchlist
Price: 13 017 Zac -1.34% Market Closed
Market Cap: 58.1B ZAR

Balance Sheet

Balance Sheet Decomposition
Aspen Pharmacare Holdings Ltd

Balance Sheet
Aspen Pharmacare Holdings Ltd

Rotate your device to view
Balance Sheet
Currency: ZAR
Jun-2002 Jun-2003 Jun-2004 Jun-2005 Jun-2006 Jun-2007 Jun-2008 Jun-2009 Jun-2010 Jun-2011 Jun-2012 Jun-2013 Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024 Jun-2025
Assets
Cash & Cash Equivalents
184
200
465
440
625
3 331
1 522
1 462
1 513
1 991
3 314
4 734
6 502
7 218
7 900
10 707
9 720
8 743
6 563
8 116
5 865
10 632
11 766
3 721
Cash
0
0
0
0
0
0
0
0
28
20
0
4 734
6 502
7 218
7 900
0
9 720
8 743
6 563
8 116
5 865
10 632
11 766
3 721
Cash Equivalents
184
200
465
440
625
3 331
1 522
1 462
1 485
1 971
3 314
0
0
0
0
10 707
0
0
0
0
0
0
0
0
Short-Term Investments
0
0
0
7
12
0
19
621
1 426
1 048
0
1 285
1 724
1 448
3 000
0
1 450
234
530
430
318
280
571
2 688
Total Receivables
327
392
379
496
672
850
1 556
1 839
2 227
3 024
3 825
4 863
0
0
9 800
12 442
12 844
12 095
12 886
10 437
12 279
13 624
13 499
13 998
Accounts Receivables
290
345
343
449
618
763
986
1 490
1 890
2 561
3 825
4 111
0
0
8 800
12 442
9 645
8 986
9 052
7 698
8 243
10 087
10 299
10 646
Other Receivables
37
47
36
47
54
87
570
349
337
463
0
752
0
0
1 000
0
3 199
3 109
3 834
2 739
4 036
3 537
3 200
3 352
Inventory
292
214
246
426
798
937
1 447
1 435
2 041
2 628
3 292
4 101
0
0
14 400
14 014
14 959
14 648
16 413
13 409
15 763
19 606
18 002
18 009
Other Current Assets
14
22
46
26
42
21
215
244
415
684
1
795
411
1 063
2 100
200
520
432
346
313
336
358
248
286
Total Current Assets
818
828
1 137
1 394
2 150
5 139
4 759
5 601
7 623
9 374
10 432
15 777
411
1 063
37 200
37 363
39 493
36 152
36 738
32 705
34 561
44 500
44 086
38 702
PP&E Net
151
511
697
936
613
2 430
6 149
7 044
10 212
11 108
3 807
4 343
0
0
9 700
9 749
11 368
12 065
14 833
15 226
16 224
18 897
20 509
21 707
PP&E Gross
151
511
697
936
613
2 430
6 149
7 044
10 212
11 108
0
4 343
0
0
9 700
0
11 368
12 065
14 833
15 226
16 224
18 897
20 509
21 707
Accumulated Depreciation
140
160
179
210
199
253
378
486
660
835
0
1 451
2 265
2 688
3 400
0
4 959
5 062
6 762
6 598
7 752
7 387
8 277
10 366
Intangible Assets
285
106
57
50
821
731
681
567
1 410
1 460
11 870
18 933
0
0
49 100
60 006
72 163
66 468
73 040
54 882
53 651
63 104
66 026
67 212
Goodwill
50
67
86
272
262
295
590
398
456
4 627
5 344
5 973
0
0
6 000
5 940
6 126
4 649
5 375
4 621
5 007
5 596
5 696
5 202
Note Receivable
0
0
0
0
0
6
5
5
32
12
32
27
299
291
200
0
940
1 018
1 145
622
351
265
654
554
Long-Term Investments
9
19
7
377
390
377
26
23
2
0
0
0
0
116
200
0
249
0
0
0
0
0
0
0
Other Long-Term Assets
193
150
125
108
34
15
1
18
66
217
234
369
0
0
1 900
2 535
1 768
1 964
2 038
1 628
1 581
1 922
2 092
2 516
Other Assets
50
67
86
272
262
295
590
398
456
4 627
5 344
5 973
0
0
6 000
5 940
6 126
4 649
5 375
4 621
5 007
5 596
5 696
5 202
Total Assets
1 505
N/A
1 682
+12%
2 110
+25%
3 136
+49%
4 269
+36%
7 532
+76%
10 849
+44%
12 522
+15%
19 801
+58%
26 797
+35%
31 719
+18%
45 422
+43%
0
N/A
0
N/A
104 300
N/A
115 593
+11%
132 107
+14%
122 316
-7%
133 169
+9%
109 684
-18%
111 375
+2%
134 284
+21%
139 063
+4%
135 893
-2%
Liabilities
Accounts Payable
363
336
353
595
713
407
537
698
1 088
1 210
2 929
2 196
3 592
3 429
3 500
10 257
4 487
3 928
3 369
3 297
3 641
3 969
4 372
4 084
Accrued Liabilities
0
0
0
0
0
105
151
231
267
629
0
1 142
1 825
1 974
2 600
0
3 843
3 286
4 007
4 980
5 468
5 404
5 314
5 975
Short-Term Debt
0
0
0
0
0
0
0
0
1 127
1 286
0
2 629
0
0
3 000
0
3 056
2 829
1 476
2 591
1 212
3 419
5 117
0
Current Portion of Long-Term Debt
161
151
290
762
1 174
3 802
5 757
2 670
2 594
3 852
4 127
5 523
0
0
7 900
18 860
8 169
5 419
4 826
22 015
10 453
4 488
6 197
4 612
Other Current Liabilities
111
119
131
134
68
317
440
621
754
1 231
264
1 375
0
0
4 100
5 689
8 645
4 577
4 401
3 868
2 621
5 868
3 302
2 825
Total Current Liabilities
635
607
775
1 491
1 954
4 630
6 885
4 220
5 830
8 208
7 320
12 865
5 418
5 403
21 100
34 806
28 200
20 039
18 079
36 751
23 395
23 148
24 302
17 496
Long-Term Debt
54
145
156
412
452
429
478
3 826
2 647
4 630
6 254
8 924
0
0
35 000
28 978
46 725
39 713
36 019
266
10 582
21 375
25 141
31 508
Deferred Income Tax
40
42
62
93
104
65
155
203
263
505
536
601
0
0
1 800
2 085
2 213
2 049
2 701
1 810
1 966
1 995
1 582
446
Minority Interest
17
7
0
0
12
7
61
80
55
61
9
5
2
23
0
27
28
2
2
0
0
0
0
0
Other Liabilities
145
92
51
34
33
18
12
9
175
167
210
234
0
0
3 900
7 333
5 594
6 302
7 153
5 230
4 490
1 530
3 177
1 550
Total Liabilities
890
N/A
894
+0%
1 043
+17%
2 030
+95%
2 556
+26%
5 149
+101%
7 591
+47%
8 339
+10%
8 970
+8%
13 571
+51%
14 329
+6%
22 628
+58%
0
N/A
0
N/A
61 800
N/A
73 229
+18%
82 760
+13%
68 105
-18%
63 954
-6%
44 057
-31%
40 433
-8%
48 048
+19%
54 202
+13%
51 000
-6%
Equity
Common Stock
51
52
52
73
1 116
908
656
672
5 205
4 911
4 703
63
0
0
2 100
1 929
2 089
2 089
2 089
2 089
2 017
2 017
2 017
2 017
Retained Earnings
403
642
949
1 269
1 029
1 805
2 712
3 681
5 762
8 396
12 686
14 872
0
0
28 500
31 655
36 386
41 295
45 959
50 821
54 412
84 567
83 208
83 239
Additional Paid In Capital
235
169
141
407
191
268
462
170
60
60
0
3 985
0
0
0
0
0
0
0
0
0
0
0
0
Treasury Stock
76
76
76
642
623
599
572
0
14
33
0
59
65
69
200
0
184
178
187
214
233
348
364
363
Other Equity
0
0
0
0
0
0
0
0
182
108
0
3 932
0
0
12 100
8 780
11 056
11 005
21 354
12 931
14 746
0
0
0
Total Equity
614
N/A
788
+28%
1 066
+35%
1 107
+4%
1 713
+55%
2 382
+39%
3 258
+37%
4 183
+28%
10 831
+159%
13 226
+22%
17 389
+31%
22 794
+31%
0
N/A
0
N/A
42 500
N/A
42 364
0%
49 347
+16%
54 211
+10%
69 215
+28%
65 627
-5%
70 942
+8%
86 236
+22%
84 861
-2%
84 893
+0%
Total Liabilities & Equity
1 505
N/A
1 682
+12%
2 110
+25%
3 136
+49%
4 269
+36%
7 532
+76%
10 849
+44%
12 522
+15%
19 801
+58%
26 797
+35%
31 719
+18%
45 422
+43%
0
N/A
0
N/A
104 300
N/A
115 593
+11%
132 107
+14%
122 316
-7%
133 169
+9%
109 684
-18%
111 375
+2%
134 284
+21%
139 063
+4%
135 893
-2%
Shares Outstanding
Common Shares Outstanding
358
361
384
385
354
357
359
361
431
433
454
455
0
0
456
456
456
456
456
455
445
444
444
444
Preferred Shares Outstanding
0
0
0
18
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett